background
need
limit
sideeffect
nanoparticl
increasingli
studi
drugcarri
target
tool
previous
report
scheme
produc
proteinbas
selfassembl
nanoparticl
act
antigen
display
platform
attempt
use
system
cancertarget
make
use
ctermin
bombesin
peptid
high
affin
receptor
known
overexpress
certain
tumor
well
ntermin
polyhistidin
tag
use
radiolabel
technetium
tricarbonyl
result
order
increas
circul
time
experi
pegyl
unpegyl
variti
typo
particl
also
test
effect
incorpor
differ
number
bombesin
per
nanoparticl
biophys
character
determin
configur
assembl
regular
particl
rel
monodispers
size
distribut
peak
nm
carbonyl
method
use
label
produc
approxim
label
nanoparticl
vitro
nanoparticl
show
high
bind
specif
nonspecif
prostat
cancer
cell
vivo
high
uptak
observ
nanoparticl
type
spleen
nunu
mice
decreas
significantli
cours
hour
high
uptak
also
observ
liver
low
uptak
seen
pancrea
tumor
xenograft
data
suggest
nanoparticl
nonspecif
taken
reticuloendotheli
system
low
uptak
pancrea
tumor
indic
littl
specif
target
pegyl
increas
amount
bombesin
per
nanoparticl
significantli
improv
target
particular
uptak
spleen
primari
organ
immun
system
highlight
potenti
nanoparticl
vaccin
carrier
also
decreas
liver
spleen
radioact
time
impli
nanoparticl
broken
clear
import
find
show
nanoparticl
safe
use
vaccin
platform
without
risk
prolong
side
effect
furthermor
demonstr
technetium
carbonyl
radiolabel
proteinbas
nanoparticl
use
evalu
pharmacokinet
properti
vivo
grow
interest
nanoparticl
variou
applic
assum
nanoparticl
would
bring
better
target
nontarget
ratio
drug
uptak
drug
deliveri
approach
interest
way
produc
nanoparticl
use
polypeptid
present
fold
unfold
form
depend
natur
concentr
salt
aqueou
solut
crucial
point
peptid
select
stick
togeth
fold
process
welldefin
amount
thu
form
spheric
nanoparticl
use
coiledcoil
domain
build
block
engin
selfassembl
protein
nanoparticl
sapn
protein
produc
genet
engin
cell
extend
n
cterminu
freeli
select
amino
acid
residu
peptid
sequenc
known
antigen
use
format
nanoparticl
result
repetit
display
antigen
use
concept
produc
promis
vaccin
candid
ill
influenza
malaria
sar
hiv
tri
use
system
develop
nanoparticl
drug
target
medic
imag
nterminu
peptid
chain
usual
compris
six
histidin
socal
histag
use
separ
engin
peptid
nintacolumn
histag
chelat
ni
column
high
affin
technetium
tricarbonyl
well
thu
use
label
technetium
carbonyl
method
cterminu
addit
linker
introduc
asnglntrpalavalglyhisleumet
name
bombesin
bn
residu
bombesin
select
known
high
affin
grp
receptor
overexpress
mani
tumor
moreov
investig
free
bombesin
peptid
mani
year
radiotrac
consist
biolog
activ
compound
radionuclid
power
tool
three
differ
area
medic
applic
name
diagnosi
therapi
drug
develop
latter
gain
increas
interest
sinc
introduct
radiolabel
drug
analogu
studi
limit
number
patient
healthi
volunt
give
insight
properti
behavior
drug
human
gener
positron
emitt
place
substitut
stabl
h
oh
use
purpos
quantif
organ
uptak
much
easier
positron
emiss
tomographi
pet
singlephoton
emiss
comput
tomographi
spect
howev
radiat
burden
pet
rather
high
consider
reduct
could
achiev
tc
label
analogu
appli
goal
studi
assess
biodistribut
radionuclidelabel
selfassembl
protein
nanoparticl
tumor
mous
model
aim
protein
chain
nanoparticl
modifi
tumor
target
peptid
bombesin
coassembl
protein
chain
without
bombesin
differ
ratio
nanoparticl
known
trap
reticuloendotheli
system
re
mainli
liver
like
label
colloid
introduc
nuclear
medicin
long
ago
sinc
elimin
blood
stream
strongli
hamper
uptak
target
tissu
also
introduc
poli
ethylen
glycol
peg
coat
particl
approach
previous
success
use
radioact
technetium
attach
histag
protein
biodistribut
assess
mous
model
figur
increas
accumul
radioact
could
observ
tumor
cell
even
particl
pegyl
howev
biodistribut
strongli
indic
nanoparticl
ideal
vaccin
candid
significantli
accumul
spleen
play
import
role
immun
system
result
support
previou
find
demonstr
nanoparticl
abil
act
effect
vaccin
want
test
whether
differ
biodistribut
nanoparticl
base
differ
densiti
target
peptid
bombesin
differ
coupl
modal
peg
nanoparticl
figur
show
amino
acid
sequenc
three
differ
peptid
use
studi
densiti
bombesin
vari
coassembl
differ
ratio
tabl
peg
moieti
either
attach
peptid
two
primari
amin
group
methionin
residu
lysin
lysin
respect
depict
orang
figur
chain
howev
lysin
side
chain
locat
two
bulki
tryptophan
residu
might
therefor
access
enough
effici
coupl
peg
moieti
also
two
coupl
site
locat
ntermin
end
nanoparticl
peptid
chain
therefor
peptid
lysin
coupl
site
engin
cterminu
therefor
peptid
lysin
coupl
site
engin
cterminu
end
peptid
surfac
modif
ggsgdppppnpndppppnpnd
previous
produc
nice
nanoparticl
henc
move
less
expos
site
nterminu
wellexpos
site
cterminu
expect
design
coupl
effici
higher
peg
moieti
surfac
expos
nanoparticl
attempt
increas
sapn
circul
time
use
pegyl
version
nanoparticl
form
peptid
peptid
pegyl
use
methoxyl
peg
succinimidyl
ester
mpegnh
denatur
condit
nhydroxylsuccinimid
nh
function
group
react
primari
amin
group
peptid
sdspage
use
analyz
pegyl
product
shown
figur
pegyl
product
extra
band
ran
slightli
monom
band
figur
left
panel
lane
c
indic
peptid
chain
pegyl
pegyl
ratio
estim
intens
two
band
shown
figur
right
panel
unpegyl
lane
e
pegyl
lane
f
product
show
similar
result
except
extra
band
ran
monom
band
pegyl
extra
band
trimer
form
protein
form
stabl
coiledcoil
even
strongli
denatur
condit
sdspage
pegyl
ratio
peptid
also
estim
intens
two
band
pegyl
reaction
often
produc
mixtur
heterogen
pegyl
compound
difficult
determin
number
locat
peg
molecul
sdspage
analysi
henc
also
difficult
detect
differ
coupl
effici
two
peptid
chain
particl
refold
use
stepwis
procedur
dynam
light
scatter
show
size
distribut
peak
nm
figur
pegyl
sampl
size
distribut
surprisingli
similar
peak
diamet
transmiss
electron
microscopi
figur
confirm
regular
spheric
particl
size
rang
form
also
appar
howev
pegyl
led
stain
artifact
imag
label
procedur
carbonyl
method
optim
yield
label
particl
impur
identifi
howev
chromatogram
obtain
purif
show
small
larg
impur
small
one
similar
size
pertechnet
larg
one
aggreg
nanoparticl
label
particl
stabl
least
one
day
correspond
four
half
live
time
tc
vitro
studi
show
pattern
experi
name
high
total
bind
cell
equal
high
nonspecif
bind
consequ
specif
bind
differ
total
nonspecif
bind
reflect
statist
error
experiment
data
biodistribut
figur
tabl
show
high
uptak
liver
spleen
quit
similar
h
h
post
inject
clear
declin
seen
h
roughli
inject
activ
trap
liver
figur
sinc
weight
liver
show
interanim
variat
mg
concentr
inject
dose
per
g
tissu
obtain
tabl
uptak
per
whole
spleen
inject
dose
case
slight
increas
h
decreas
h
post
inject
seen
figur
diverg
behavior
concern
time
cours
idg
tabl
tclabel
decreas
strongli
idg
h
idg
h
reason
variabl
weight
spleen
experi
anim
light
heavi
spleen
rather
uniformli
distribut
among
type
particl
time
point
case
happen
h
group
light
spleen
averag
g
h
group
rather
heavi
spleen
averag
g
three
type
particl
show
uptak
h
post
inject
specif
bombesin
mediat
uptak
would
show
elev
valu
tc
activ
pancrea
tumor
howev
agreement
vitro
data
observ
uptak
stomach
colon
low
close
intestin
time
point
pegyl
appear
significantli
affect
biodistribut
nanoscal
assembl
repres
new
interest
approach
develop
vaccin
technolog
particular
proteinbas
assembl
attract
choic
vaccin
platform
safeti
flexibl
design
sapn
system
util
work
addit
benefit
easi
produc
biophys
well
character
abl
elicit
respons
even
poorli
immunogen
peptid
consequ
success
use
sapn
vaccin
number
import
diseas
genet
engin
protein
nanoparticl
radiolabel
histag
tool
prepar
particl
uniform
size
studi
vivo
behavior
nanoparticl
show
rather
monodispers
size
distribut
affect
coupl
peg
nanoparticl
uptak
pattern
liver
spleen
figur
reflect
nonspecif
uptak
re
mainli
depend
size
mayb
lipophilicityhydrophil
particl
surfac
et
al
shown
lower
spleen
uptak
correl
higher
lipophil
surprisingli
observ
exactli
opposit
hydrophil
henc
less
lipophil
less
accumul
spleen
figur
peptid
ggsgdppppnpndppppnpndk
carri
four
charg
quit
hydrophil
furthermor
incorpor
higher
proport
hydrophob
bombesin
nanoparticl
uptak
spleen
increas
liver
uptak
around
inject
dose
h
inject
show
virtual
variat
uptak
spleen
around
inject
dose
consider
lower
particl
observ
uptak
quit
similar
distribut
observ
tc
label
colloid
prepar
attribut
properti
re
depend
natur
colloid
basic
size
particl
increas
uptak
either
liver
spleen
bone
marrow
seen
uptak
liver
quit
high
would
expect
proteinbas
materi
unfortun
uptak
could
reduc
pegyl
nanoparticl
stay
roughli
prepar
use
studi
washout
activ
liver
spleen
interpret
degrad
particl
well
agreement
biolog
function
organ
total
activ
clear
via
kidney
urin
could
determin
howev
activ
concentr
urin
gener
around
inject
dose
per
ml
urin
sinc
intact
particl
roughli
ten
time
larger
compound
would
pass
glomerulum
cut
kda
nm
diamet
clearanc
must
due
broken
particl
short
peptid
chain
anoth
possibl
would
simpli
decomposit
tccomplex
howev
tccomplex
would
destroy
free
tc
would
oxid
rapidli
pertechnet
subsequ
would
lead
increas
uptak
stomach
uptak
observ
vitro
test
show
high
bind
cell
increas
time
time
cours
slightli
differ
depend
natur
nanoparticl
howev
experi
show
specif
uptak
could
attribut
bombesin
moieti
particl
surfac
shown
selfassembl
protein
nanoparticl
accumul
immun
organ
spleen
therefor
potenti
immunogen
support
earlier
research
use
sapn
vaccin
studi
also
show
nanoparticl
might
safe
appli
metabol
elimin
least
indic
longterm
problem
must
consid
respect
also
shown
radiolabel
nanoparticl
tool
high
potenti
perform
pharmacokinet
studi
nanoparticl
vaccin
note
origin
plan
applic
sapn
present
name
drug
target
imag
appear
feasibl
time
warrant
develop
peptid
consist
pentamer
coiledcoil
domain
deriv
cartilag
oligomer
matrix
protein
comp
link
trimer
coiledcoil
domain
de
novo
design
peptid
histag
sequenc
amino
acid
black
nterminu
follow
pentamer
domain
amino
acid
green
trimer
domain
amino
acid
peptid
creat
base
peptid
lysin
residu
cterminu
peptid
sequenc
extend
ctermin
end
flexibl
linker
gsgsgsgsg
nine
residu
nqwavghlm
peptid
bombesin
sequenc
shown
figur
plasmid
carri
gene
transform
compet
plyss
e
coli
cell
novagen
madison
wi
ad
plasmid
cell
allow
mixtur
cool
ice
minut
cell
treat
heat
shock
second
cool
cell
ice
minut
soc
medium
ad
cultur
grown
shake
rpm
minut
cultur
spread
lbagar
plate
contain
ampicillin
chloramphenicol
left
overnight
peptid
express
inocul
ml
luria
broth
contain
ampicillin
chloramphenicol
singl
isol
coloni
transform
plate
cultur
grown
overnight
follow
day
ml
use
inocul
l
luria
broth
contain
ampicillin
chloramphenicol
cell
allow
grow
shake
rpm
od
express
induc
addit
isopropyl
cell
grown
addit
hour
harvest
centrifug
rpm
minut
cell
pellet
store
purif
cell
resuspend
lysi
buffer
urea
mm
tri
ph
mm
nah
po
lyse
sonic
lysat
clarifi
centrifug
minut
clear
lysat
pass
nickel
affin
column
ge
healthcar
waukesha
wi
wash
first
lysi
buffer
high
phosphat
buffer
urea
mm
tri
ph
mm
nah
po
mm
imidazol
column
wash
urea
mm
citrat
mm
nah
po
mm
imidazol
three
differ
ph
valu
final
column
wash
lysi
buffer
contain
increas
concentr
imidazol
puriti
collect
fraction
determin
sd
page
purifi
peptid
dialyz
imidazolefre
buffer
urea
mm
tri
ph
mm
nacl
mm
edta
pegyl
agent
mpegnh
kda
purchas
nanoc
inc
new
york
usa
peptid
concentr
mgml
buffer
contain
mm
sodium
phosphat
sd
mpegnh
powder
ad
concentr
peptid
solut
mm
sodium
phosphat
ph
sd
incub
rpm
shake
room
temperatur
reaction
mixtur
molar
ratio
mpegnh
peptid
pegyl
reaction
excess
mpegnh
remov
use
dialysi
membran
mwco
kda
spectrum
laboratori
inc
ca
usa
product
mixtur
analyz
use
sdspage
use
without
purif
unpegyl
particl
two
peptid
first
dialyz
denatur
buffer
urea
mm
hepe
ph
mm
nacl
glycerol
filter
filter
millipor
billerica
mix
ratio
mole
mole
mix
peptid
solut
dilut
filter
denatur
buffer
final
peptid
concentr
approxim
mgml
refold
done
stepwis
dialysi
buffer
mm
hepe
ph
mm
nacl
glycerol
success
lower
urea
concentr
step
urea
urea
use
twice
ensur
remov
residu
urea
pegyl
sampl
pegyl
product
previou
step
directli
use
coassembl
unpegyl
without
purif
pegyl
product
filter
denatur
denatur
buffer
describ
mix
appropri
molar
ratio
unpegyl
tabl
dilut
approxim
mgml
refold
perform
direct
dialysi
urea
buffer
urea
step
perform
twice
remov
residu
urea
dynam
light
scatter
experi
carri
zetas
nano
instrument
malvern
worcestershir
uk
nm
hene
laser
measur
carri
mm
hepe
ph
mm
nacl
glycerol
sampl
neg
stain
uranyl
acet
spi
suppli
westchest
pa
usa
observ
fei
tecnai
stem
acceler
voltag
kv
fei
hillsboro
oregon
label
tc
done
two
step
first
ml
tc
pertechnet
obtain
motcgener
ultratechnecow
mallinckrodt
ad
mixtur
mg
sodium
boranocarbon
mg
borax
mg
sodium
potassium
tartrat
heat
around
min
obtain
solut
tc
co
h
cool
room
temperatur
neutral
hydrochlor
acid
buffer
phosphat
buffer
ph
second
step
solut
depend
activ
concentr
gener
eluat
mix
ml
suspens
mgml
respect
sapn
kept
h
cool
final
product
purifi
column
sinc
label
yield
two
flowthrough
cell
one
equip
uv
detector
radioact
detector
use
analyz
eluat
human
prostat
adenocarcinoma
cell
line
obtain
european
collect
cell
cultur
ecacc
salisburi
england
cell
maintain
dmem
glutamaxi
supplement
fc
iuml
penicillin
g
sodium
streptomycin
sulfat
amphotericin
b
cell
incub
atmospher
contain
co
twice
weekli
subcultur
detach
trypsinedta
intern
cell
confluenc
place
plate
left
attach
overnight
cell
incub
label
analogu
kbq
cultur
medium
h
final
volum
mlwell
nonspecif
bind
determin
unlabel
bn
residu
unlabel
particl
differ
incub
time
cell
wash
twice
cold
pb
discard
unbound
peptid
surfacebound
activ
remov
acid
wash
mm
glycinhcl
mm
nacl
ph
twice
appli
room
temperatur
afterward
plate
wash
cold
pb
cell
lyse
naoh
twice
surfacebound
intern
radioact
measur
gamma
counter
addit
experi
carri
intern
inhibitor
sucros
mm
phenylarsinoxid
mm
mm
genistin
mm
chloroquin
mm
cytocalsin
b
mm
cell
place
differ
concentr
million
cellswel
plate
incub
h
kbq
tc
label
sapnbn
nonspecif
bind
determin
presenc
unlabel
bombesin
incub
supernat
discard
cell
wash
twice
pb
detach
cell
well
wash
time
n
naoh
activ
measur
counter
anim
experi
conduct
complianc
swiss
anim
protect
law
ethic
principl
guidelin
scientif
anim
experiment
establish
swiss
academi
medic
natur
scienc
biodistribut
studi
perform
femal
nunu
mice
g
purchas
charl
river
laboratori
sulzfeld
germani
induct
tumor
xenograft
mous
receiv
subcutan
cell
cultur
medium
without
supplement
tumor
allow
grow
least
three
week
day
experi
mice
per
group
receiv
label
nanoparticl
intraven
h
post
inject
pi
anim
euthan
dissect
blood
tumor
variou
healthi
tissu
organ
collect
weigh
amount
radioact
tissu
determin
measur
sampl
gamma
counter
decay
correct
refer
time
time
inject
result
express
percentag
inject
dose
per
gram
tissu
idg
abbrevi
sapn
selfassembl
protein
nanoparticl
bn
bombesin
peg
poli
ethylen
glycol
pet
positron
emiss
tomographi
spect
singlephoton
emiss
comput
tomographi
re
reticuloendotheli
system
nh
nhydroxylsuccinimid
tc
comp
cartilag
oligomer
matrix
protein
pbu
ua
interest
compani
alphao
peptid
patent
patent
pend
technolog
author
contribut
yy
tn
synthes
particl
perform
biophys
character
cm
provid
construct
plasmid
egg
pbl
perform
radiolabel
vitro
vivo
studi
rs
ua
pbu
develop
sapn
concept
gave
direct
experi
author
contribut
plan
write
review
manuscript
author
read
approv
final
manuscript
